Bioceltix SA
WSE:BCX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bioceltix SA
WSE:BCX
|
PL |
|
S
|
SNC Former PCL
SET:SNC
|
TH |
|
M
|
Maple Peak Investments Inc
XTSX:MAP
|
CA |
|
Anthera Pharmaceuticals Inc
OTC:ANTH
|
US |
|
T
|
TinOne Resources Inc
OTC:TORCF
|
CA |
|
S & T Corporation Ltd
BSE:514197
|
IN |
|
R
|
Regina Miracle International (Holdings) Ltd
F:RMT
|
HK |
|
Hohsui Corp
TSE:1352
|
JP |
|
C
|
City Sports and Recreation PCL
SET:CSR
|
TH |
|
P
|
Pluribus Technologies Corp
XTSX:PLRB
|
CA |
|
Echo Investment SA
F:4I3
|
PL |
|
A
|
Attock Refinery Ltd
KAR:ATRL
|
PK |
|
I
|
Impresa Sociedade Gestora de Participacoes Sociais SA
ELI:IPR
|
PT |
|
M
|
Modular Medical Inc
NASDAQ:MODD
|
US |
|
B
|
Brite-Tech Bhd
KLSE:BTECH
|
MY |
|
Pacific Imperial Mines Inc
OTC:PCIMF
|
CA |
|
Central Retail Corporation PCL
SET:CRC
|
TH |
|
P
|
Porvair PLC
OTC:PVARF
|
UK |
|
Z
|
Zenith Fibres Ltd
BSE:514266
|
IN |
|
R
|
Rovita SA
WSE:ROV
|
PL |
|
Innelec Multimedia SA
F:1W2
|
FR |
|
T
|
TFBS Bioscience Inc
TPEX:6939
|
TW |
|
R
|
Rank Group PLC
OTC:RANKF
|
UK |
|
LBT Innovations Ltd
ASX:CC5
|
AU |
Wall St Price Targets
BCX Price Targets Summary
Bioceltix SA
According to Wall Street analysts, the average 1-year price target for BCX is 132.75 PLN with a low forecast of 128.57 PLN and a high forecast of 139.65 PLN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BCX's stock price target?
Price Target
132.75
PLN
According to Wall Street analysts, the average 1-year price target for BCX is 132.75 PLN with a low forecast of 128.57 PLN and a high forecast of 139.65 PLN.